Calidi Biotherapeutics (CLDWW) Q1 2026 Earnings

27MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-2.21
-1.66
-1.12
-0.57

Details

Expected EPS
-1.56
Actual EPS
-0.57
Surprise EPS
0.99
Surprise Percent
+63.46%

Description

Calidi Biotherapeutics (CLDWW) has reported earnings of -0.57 per share for Q1 2026.

0 Comments

Share your thoughts